APLT – applied therapeutics, inc. (US:NASDAQ)
Stock Stats
News
12/16
11:21 am
aplt
Medium
Halper Sadeh LLC Encourages QIPT, FITB, GBIO, APLT Shareholders to Contact the Firm to Discuss Their Rights
12/13
07:49 am
aplt
Medium
Applied Therapeutics (NASDAQ:APLT) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
12/12
01:05 pm
aplt
Low
Applied Therapeutics (NASDAQ:APLT) was given a new $0.25 price target on by analysts at Robert W. Baird.
12/12
10:09 am
aplt
Low
Applied Therapeutics (NASDAQ:APLT) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating.
12/12
06:54 am
aplt
High
APLT Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Applied Therapeutics, Inc. is Fair to Shareholders
11/13/2025
07:00 am
aplt
-52.6%
BEAT
8/13/2025
05:11 pm
aplt
7.3%
BEAT
5/13/2025
05:00 pm
aplt
9.0%
BEAT
12/12
10:09 am
Downgrades
Outperform
Neutral
Robert W. Baird
Low
1.8%
12/12
08:36 am
Downgrades
OUTPERFORM
NEUTRAL
BAIRD
High
-14.0%
12/12
08:36 am
Downgrades
OUTPERFORM
NEUTRAL
BAIRD
High
-14.0%
12/3
08:46 am
Downgrades
Outperform
Market Perform
Leerink Partners
Low
-1.7%
12/3
08:44 am
Downgrades
Outperform
Market Perform
Leerink Partners
Low
1.3%
12/18
03:14 pm
aplt
Neutral
Form 4 Applied Therapeutics, For: Dec 16 Filed by: Kanter Stacy J.
12/16
11:05 am
aplt
Medium
Form 144 Applied Therapeutics, Filed by: Kanter Stacy J.
12/15
05:38 pm
aplt
Medium
Form SCHEDULE 13G/A Applied Therapeutics, Filed by: ALEXANDRIA REAL ESTATE EQUITIES, INC.
12/12
06:02 am
aplt
High
Form 8-K Applied Therapeutics, For: Dec 11
12/12
06:02 am
aplt
High
Form SC14D9C Applied Therapeutics, Filed by: Applied Therapeutics, Inc.
Show more
Top News Gainers
1/8 Applied Therapeutics Announces Positive Topline Results of Pivotal Phase 2 ACTION-Galactosemia Study of AT-007 in Galactosemia Patients 41.5%
1/9 Applied Therapeutics (NASDAQ: APLT) had its price target raised by analysts at Citigroup Inc from $29.00 to $44.00. They now have a "buy" rating on the stock. 25.7%
5/13 Form 3 Applied Therapeutics For: May 13 Filed by: Funtleyder Leslie D. 16.9%
12/23 Form EFFECT Applied Therapeutics 14.4%
4/3 Form 3 Applied Therapeutics For: Apr 01 Filed by: Mahadevan Chids 9.9%
12/19 Form S-1/A Applied Therapeutics 7.3%
1/29 Form 4 Applied Therapeutics For: Jan 28 Filed by: MARCUS JOEL S 7.1%
3/13 Form 8-K Applied Therapeutics For: Mar 13 7.0%
3/3 Applied Therapeutics Appoints Adam Hansard as Chief Commercial Officer 6.5%
6/10 Applied Therapeutics (NASDAQ: APLT) is now covered by analysts at Robert W. Baird. They set an "outperform" rating on the stock. 6.5%
Top News Decliners
3/16 Form POS AM Applied Therapeutics -29.8%
3/10 Applied Therapeutics (NASDAQ: APLT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -13.2%
3/11 Form 4 Applied Therapeutics For: Mar 09 Filed by: Hansard Adam -11.9%
4/21 Applied Therapeutics Announces Full Data and Scientific Presentations from the Pivotal Phase 2 ACTION-Galactosemia Trial -11.8%
6/21 Applied Therapeutics Reports First Quarter 2019 Financial Results -11.0%
12/5 Applied Therapeutics Announces Presentations Outlining the Design and Rationale for the ARISE-HF Pivotal Study of AT-001 for Treatment of Diabetic Cardiomyopathy at the 16th Annual Global Cardiovascular Clinical Trialist’s Forum (CVCT) -10.4%
3/31 Form 4 Applied Therapeutics For: Mar 27 Filed by: Alexandria Venture Investments, LLC -10.0%
3/5 Applied Therapeutics (APLT) Investor Presentation - Slideshow [Seeking Alpha] -9.3%
6/5 Form 4 Applied Therapeutics For: Jun 03 Filed by: Funtleyder Leslie D. -9.0%
8/8 Applied Therapeutics Reports AT-007 SAD Data from Healthy Volunteer Portion of Phase 1/2 ACTION-Galactosemia Study -8.1%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3